As the global population continues to age, demand for effective prostate care is steadily increasing. A multinational study spanning 25 countries found that the prevalence of symptoms associated with benign prostatic hyperplasia (BPH) rises from approximately 20% among men aged 50–59 to 37% among those aged 70–79. The Global Burden of Disease (GBD) study further estimates that approximately 94 million men worldwide are affected by BPH.
Prostate cancer shows a similarly strong association with age. According to the International Agency for Research on Cancer (IARC), approximately 1.47 million new cases were diagnosed worldwide in 2022, while Global Burden of Disease data indicate that more than 70% of new cases occur in men aged 65 and older.
As clinical demand grows, prostate care is evolving beyond conventional tissue removal toward more precise, less invasive, and increasingly tissue-preserving energy-based therapies. This shift is also transforming procedural equipment from standalone surgical tools into sophisticated medical platforms that seamlessly integrate energy delivery, closed-loop control, real-time sensing, and patient-side procedural devices.
From Tissue Removal to Precision Energy Control
Modern minimally invasive prostate therapies encompass a range of modalities depending on the clinical objective and system architecture, including thermal energy, focused ultrasound (HIFU), laser ablation, cryotherapy, and pulsed electric fields.
Although these technologies rely on different energy sources and mechanisms of action, they share a common clinical objective:
In thermal therapies, for example, controlled energy is delivered to targeted prostate tissue to create a localized thermal effect, allowing the treated tissue to be gradually resorbed or remodeled over time. Focused ultrasound concentrates acoustic energy at a defined treatment site, while pulsed electric field technologies use short-duration electrical fields to alter cell membranes within the targeted zone.
For modern procedural systems, the challenge is therefore no longer simply generating sufficient energy. It lies in precisely controlling energy output, exposure duration, and treatment location to achieve consistent and predictable performance.
Four Key Technical Challenges in Next-Generation Medical Systems
1. Stable Energy Delivery & Power Management
Energy-based therapies require reliable power delivery. Interconnects must support high current capacity, low contact resistance, and controlled temperature rise to maintain consistent energy output throughout treatment.
2. Signal Integrity & EMI Mitigation for Sensing Data
Next-generation systems rely on real-time sensor feedback. Integrating power and low-level signals within compact interfaces requires effective signal isolation, grounding, and EMI shielding to maintain signal integrity.
3. Reliable Interfaces for Single-Use & Reusable Instruments
Treatment instruments require quick, correct, and secure connections. Anti-mismating keying, secure locking, and strain relief help reduce connection risks across both single-use and reusable devices.
4. Miniaturization & Multi-Signal Integration
Compact treatment devices demand multifunctional interfaces. High-density contacts and custom hybrid cable assemblies integrate power, signals, and sensor connections into a smaller footprint while reducing I/O complexity.
From Console to Patient: Interconnects as a Critical Link in System Reliability
In energy-based medical platforms, therapeutic success hinges on the synchronized operation between the main console, control modules, connectors, cable assemblies, and patient-side devices. Any instability at a connection point can compromise energy delivery, corrupt sensor data, or disrupt control signals. For minimally invasive prostate treatment systems, typical interconnect nodes include:
Supporting Next-Generation Interconnect Needs in Minimally Invasive Devices
As prostate therapies advance toward greater miniaturization, precision energy control, and real-time sensing, system interconnect requirements are becoming increasingly complex.
Backed by extensive expertise in medical interconnect technology, NEXTRON provides medical-grade circular connectors, custom multi-contact configurations, and overmolded cable assembly solutions tailored to different system locations and functional demands—from main consoles and control modules to patient-side instruments.
For next-generation energy-based treatment systems, NEXTRON empowers medical device manufacturers (OEMs) by:
● Reliably integrating power and control signals into hybrid designs
● Supporting high-fidelity sensor feedback and status monitoring
● Implementing anti-mismating keying and secure auto-locking mechanisms
● Designing versatile interfaces for both single-use and reusable treatment tools
● Optimizing handpiece and cable assembly miniaturization
● Enhancing overall interconnect reliability for medical-grade equipment
● Enhancing overall interconnect reliability for medical-grade equipment
NEXTRON remains dedicated to supporting medical device manufacturers with medical-grade interconnect solutions and custom cable assemblies—enabling the development of next-generation, precision energy-based medical technologies.
